董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Andrew Cavanna | 男 | Director | 51 | 未披露 | 未持股 | 2026-01-28 |
| Pavithra Mahesh | 女 | Director | 36 | 未披露 | 未持股 | 2026-01-28 |
| Marilyn Tavenner | 女 | Director | 74 | 20.00万美元 | 1.98 | 2026-01-28 |
| Richard Zoretic | 男 | Director | 67 | 20.00万美元 | 6.85 | 2026-01-28 |
| James Carlson | 男 | Chair of the Board | 73 | 38.40万美元 | 6.20 | 2026-01-28 |
| Teresa Sparks | 女 | Director | 57 | 22.00万美元 | 未持股 | 2026-01-28 |
| Patricia Fontneau | 女 | Director | 64 | 22.00万美元 | 3.68 | 2026-01-28 |
| John Ellis Bush | 男 | Director | 73 | 20.00万美元 | 1.98 | 2026-01-28 |
| Thomas A. Scully | 男 | Director | 70 | 未披露 | 10.00 | 2026-01-28 |
| Sean M. Traynor | 男 | Director | 57 | 未披露 | 未持股 | 2026-01-28 |
| Ted Kennedy, Jr. | 男 | Director | 64 | 20.00万美元 | 4.28 | 2026-01-28 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Nicole D'Amato | 女 | Chief Legal Officer and Corporate Secretary | 47 | 76.61万美元 | 11.19 | 2026-01-28 |
| Patrick Blair | 男 | Chief Executive Officer | 55 | 154.70万美元 | 75.48 | 2026-01-28 |
| Richard Feifer | 男 | Chief Medical Officer | 58 | 133.87万美元 | 未持股 | 2026-01-28 |
| Benjamin C. Adams | 男 | Chief Financial Officer | 62 | 251.34万美元 | 未持股 | 2026-01-28 |
董事简历
中英对照 | 中文 | 英文- Andrew Cavanna
-
Andrew Cavanna自2017年以来一直担任Apax梦百合团队的合伙人。在加入Apax之前，Andrew在Vestar Capital Partners工作了11年，担任董事总经理和梦百合部门联合主管。Cavanna先生目前任职于Kepro的董事会，这是一家美国的护理协调和质量保证服务提供商。Cavanna先生在康奈尔大学（Cornell University）获得学士学位，并在哥伦比亚商学院（Columbia Business School）获得工商管理硕士学位。
Andrew Cavanna began serving on InnovAge Holding Corp. Board in March 2021. Mr. Cavanna has served as a Partner at Apax Partners since 2017. Prior to joining Apax Partners, Mr. Cavanna spent eleven years at Vestar Capital Partners where he was a Managing Director and Co Head of the Healthcare Sector. Mr. Cavanna currently serves on the Advisory Council of the Cornell College of Arts and Sciences and as an instructor at the Harvard School of Public Health. Previoly, Mr. Cavanna served as chair of the board of directors of Eating Recovery Center, an eating disorder treatment center, and on the board of Keystone Peer Review Organization, Inc. (Kepro, now part of Acentra Health), a provider of care coordination and quality assurance services for government healthcare programs in the United States. Previoly, Mr. Cavanna served as a member of the board for Institutional Shareholder Services from May 2014 to July 2017, and for Press Ganey Associates from March 2008 to October 2016, when the company was taken private. Earlier in his career, Mr. Cavanna worked at The Blackstone Group, JPMorgan Partners, and Merrill Lynch. Mr. Cavanna earned a Bachelor's Degree from Cornell University and a Master of Biness Administration from Columbia Biness School. - Andrew Cavanna自2017年以来一直担任Apax梦百合团队的合伙人。在加入Apax之前，Andrew在Vestar Capital Partners工作了11年，担任董事总经理和梦百合部门联合主管。Cavanna先生目前任职于Kepro的董事会，这是一家美国的护理协调和质量保证服务提供商。Cavanna先生在康奈尔大学（Cornell University）获得学士学位，并在哥伦比亚商学院（Columbia Business School）获得工商管理硕士学位。
- Andrew Cavanna began serving on InnovAge Holding Corp. Board in March 2021. Mr. Cavanna has served as a Partner at Apax Partners since 2017. Prior to joining Apax Partners, Mr. Cavanna spent eleven years at Vestar Capital Partners where he was a Managing Director and Co Head of the Healthcare Sector. Mr. Cavanna currently serves on the Advisory Council of the Cornell College of Arts and Sciences and as an instructor at the Harvard School of Public Health. Previoly, Mr. Cavanna served as chair of the board of directors of Eating Recovery Center, an eating disorder treatment center, and on the board of Keystone Peer Review Organization, Inc. (Kepro, now part of Acentra Health), a provider of care coordination and quality assurance services for government healthcare programs in the United States. Previoly, Mr. Cavanna served as a member of the board for Institutional Shareholder Services from May 2014 to July 2017, and for Press Ganey Associates from March 2008 to October 2016, when the company was taken private. Earlier in his career, Mr. Cavanna worked at The Blackstone Group, JPMorgan Partners, and Merrill Lynch. Mr. Cavanna earned a Bachelor's Degree from Cornell University and a Master of Biness Administration from Columbia Biness School.
- Pavithra Mahesh
-
Pavithra Mahesh于2018年加入Apax，是其梦百合团队的负责人。在加入Apax之前，Mahesh女士是高盛（Goldman Sachs）的投资专业人士，她在该公司专注于梦百合服务和信息技术领域的收购和成长型股权投资。Mahesh女士在杜克大学（Duke University）获得学士学位，并在哈佛商学院（Harvard Business School）获得工商管理硕士学位。
Pavithra Mahesh,currently serves as a Principal on the services team at Apax Partners, a private equity investment firm that she joined in 2018. Prior to joining Apax Partners, Ms. Mahesh was an investment professional at Goldman Sachs, where she focused on buyouts and growth equity investments in healthcare services and information technology. Ms. Mahesh previously served as a director of the Company, initially joining the Board in 2020, prior to the Company's initial public offering, and continuing in that role through March 2023. Ms. Mahesh earned a Bachelor of Arts in Behavioral Economics from Duke University and a Master of Business Administration from Harvard Business School. - Pavithra Mahesh于2018年加入Apax，是其梦百合团队的负责人。在加入Apax之前，Mahesh女士是高盛（Goldman Sachs）的投资专业人士，她在该公司专注于梦百合服务和信息技术领域的收购和成长型股权投资。Mahesh女士在杜克大学（Duke University）获得学士学位，并在哈佛商学院（Harvard Business School）获得工商管理硕士学位。
- Pavithra Mahesh,currently serves as a Principal on the services team at Apax Partners, a private equity investment firm that she joined in 2018. Prior to joining Apax Partners, Ms. Mahesh was an investment professional at Goldman Sachs, where she focused on buyouts and growth equity investments in healthcare services and information technology. Ms. Mahesh previously served as a director of the Company, initially joining the Board in 2020, prior to the Company's initial public offering, and continuing in that role through March 2023. Ms. Mahesh earned a Bachelor of Arts in Behavioral Economics from Duke University and a Master of Business Administration from Harvard Business School.
- Marilyn Tavenner
-
Marilyn Tavenner于2011年至2013年担任Medicare&Medicaid Services中心的代理管理员，并于2013年至2015年担任管理员。2015年至2018年，Tavenner女士担任代表保险公司的全国性协会America&8217；s Health Insurance Plans的总裁兼首席执行官。Tavenner女士目前在Select Medical的董事会和审计委员会任职。Tavenner女士在弗吉尼亚联邦大学（Virginia Commonwealth University）获得护理理学学士学位和卫生管理硕士学位。
Marilyn Tavenner,began serving on Innovage Holding Corp. Board in March 2021. Ms. Tavenner served as acting Administrator for the Centers for Medicare & Medicaid Services from 2010 to 2013, and she was Administrator from 2013 to 2015. From 2015 to 2018, Ms. Tavenner was President and Chief Executive Officer of America's Health Insurance Plans, a national association representing insurers. Ms. Tavenner currently serves on the board of directors and as a member and chair of the quality and safety committee and governance committee, respectively, of Select Medical Holdings Corp. (NYSE: SEM). Additionally, Ms. Tavenner serves on the board of directors and member of the finance and compensation committee of Blue Cross Blue Shield of Arizona. Ms. Tavenner earned a Bachelor of Science in Nursing and a Master's in Health Administration from Virginia Commonwealth University. - Marilyn Tavenner于2011年至2013年担任Medicare&Medicaid Services中心的代理管理员，并于2013年至2015年担任管理员。2015年至2018年，Tavenner女士担任代表保险公司的全国性协会America&8217；s Health Insurance Plans的总裁兼首席执行官。Tavenner女士目前在Select Medical的董事会和审计委员会任职。Tavenner女士在弗吉尼亚联邦大学（Virginia Commonwealth University）获得护理理学学士学位和卫生管理硕士学位。
- Marilyn Tavenner,began serving on Innovage Holding Corp. Board in March 2021. Ms. Tavenner served as acting Administrator for the Centers for Medicare & Medicaid Services from 2010 to 2013, and she was Administrator from 2013 to 2015. From 2015 to 2018, Ms. Tavenner was President and Chief Executive Officer of America's Health Insurance Plans, a national association representing insurers. Ms. Tavenner currently serves on the board of directors and as a member and chair of the quality and safety committee and governance committee, respectively, of Select Medical Holdings Corp. (NYSE: SEM). Additionally, Ms. Tavenner serves on the board of directors and member of the finance and compensation committee of Blue Cross Blue Shield of Arizona. Ms. Tavenner earned a Bachelor of Science in Nursing and a Master's in Health Administration from Virginia Commonwealth University.
- Richard Zoretic
-
Richard Zoretic，在2014年退休之前，Zoretic先生曾担任WellPoint，Inc.的执行Vice President，并担任该公司政府业务部门总裁，该业务包括WellPoint，Inc.的医疗补助，医疗保险，Caremore和联邦雇员计划业务。加入WellPoint，Inc.之前Zoretic从2007年到2012年担任Amerigroup Corporation首席运营官，全面负责公司运营，包括当地医疗计划、医疗管理计划、供应商网络、医疗保健分析、信息技术和客户服务运营。Zoretic先生在宾夕法尼亚州立大学（Pennsylvania State University）获得金融学理学学士学位。Zoretic先生目前在Molina梦百合的董事会和审计委员会任职。
Richard Zoretic,began serving on Innovage Holding Corp. Board in March 2021. Prior to his retirement in 2014, Mr. Zoretic served as Executive Vice President of WellPoint, Inc. and President of the company's Government Business Division, a business encompassing WellPoint, Inc.'s Medicaid, Medicare, CareMore and Federal Employee Program businesses. Prior to joining WellPoint, Inc. Mr. Zoretic served as Chief Operating Officer of Amerigroup Corporation from 2007 to 2012, where he had overall responsibility for company operations including local health plans, medical management programs, provider networks, health care analytics, information technology and customer service operations. Mr. Zoretic currently serves on the board of directors, the compliance and quality committee and the audit committee of Molina Healthcare, Inc. (NYSE: MOH). Mr. Zoretic served on the board of directors and audit committee of Aveanna Healthcare Holdings, Inc. (Nasdaq: AVAH) from 2017 to June 2024. Mr. Zoretic earned a Bachelor of Science in Finance from Pennsylvania State University. - Richard Zoretic，在2014年退休之前，Zoretic先生曾担任WellPoint，Inc.的执行Vice President，并担任该公司政府业务部门总裁，该业务包括WellPoint，Inc.的医疗补助，医疗保险，Caremore和联邦雇员计划业务。加入WellPoint，Inc.之前Zoretic从2007年到2012年担任Amerigroup Corporation首席运营官，全面负责公司运营，包括当地医疗计划、医疗管理计划、供应商网络、医疗保健分析、信息技术和客户服务运营。Zoretic先生在宾夕法尼亚州立大学（Pennsylvania State University）获得金融学理学学士学位。Zoretic先生目前在Molina梦百合的董事会和审计委员会任职。
- Richard Zoretic,began serving on Innovage Holding Corp. Board in March 2021. Prior to his retirement in 2014, Mr. Zoretic served as Executive Vice President of WellPoint, Inc. and President of the company's Government Business Division, a business encompassing WellPoint, Inc.'s Medicaid, Medicare, CareMore and Federal Employee Program businesses. Prior to joining WellPoint, Inc. Mr. Zoretic served as Chief Operating Officer of Amerigroup Corporation from 2007 to 2012, where he had overall responsibility for company operations including local health plans, medical management programs, provider networks, health care analytics, information technology and customer service operations. Mr. Zoretic currently serves on the board of directors, the compliance and quality committee and the audit committee of Molina Healthcare, Inc. (NYSE: MOH). Mr. Zoretic served on the board of directors and audit committee of Aveanna Healthcare Holdings, Inc. (Nasdaq: AVAH) from 2017 to June 2024. Mr. Zoretic earned a Bachelor of Science in Finance from Pennsylvania State University.
- James Carlson
-
詹姆斯·卡尔森于2022年6月开始担任InnovAge Holding Corp.董事会主席和成员。2013年至2015年，卡尔森先生担任Omnicare Inc.（纽约证券交易所代码：OCR）的董事，该公司被CVS制药公司收购。在此之前，他曾于2007年9月至2012年12月担任Amerigroup Corp.的首席执行官、总裁和董事会主席。Amerigroup Corp.是一家由多个州管理的医疗保健公司，在Amerigroup与WellPoint Inc.（现名：Elevance Health, Inc.，纽约证券交易所代码：ELV）合并后退休。2003年至2007年，他担任Amerigroup总裁兼首席运营官。在此之前，他是联合健康公司（纽约证券交易所代码：UNH）的执行副总裁和联合保健业务部门的总裁，该部门为全国超过一千万的HMO和OPPO计划会员提供服务。卡尔森先生的丰富经验还包括在保德信金融集团（纽约证券交易所代码：PRU）工作了17年。卡尔森先生是家庭送餐服务公司PurFoods LLC的董事会成员，也是Guidon Partners的联合创始人。卡尔森先生曾就读于晨兴大学，并毕业于莱德大学。
James Carlson,began serving as Chair and member of Innovage Holding Corp. Board in June 2022. Mr. Carlson served as director of Omnicare Inc. (NYSE: OCR) from 2013 through 2015 when the company was acquired by CVS Pharmacy, Inc. Prior to that, he was the Chief Executive Officer, President and Chairman of the Board of Amerigroup Corp., a multi-state managed healthcare company, from September 2007 through December 2012, retiring after Amerigroup merged with WellPoint Inc. (now known as Elevance Health, Inc. (NYSE: ELV)). He was Amerigroup's President and Chief Operating Officer from 2003 to 2007. Prior to that, he was Executive Vice President of UnitedHealth Group, Inc. (NYSE: UNH) and President of its UnitedHealthcare business unit, which served more than ten million members in HMO and PPO plans nationwide. Mr. Carlson's diverse experience also includes over 17 years with Prudential Financial, Inc. (NYSE: PRU) Mr. Carlson is a member of the board of directors PurFoods LLC, a home meal delivery service, and is co-founder of Guidon Partners. Mr. Carlson attended Morningside University and graduated from Rider University. - 詹姆斯·卡尔森于2022年6月开始担任InnovAge Holding Corp.董事会主席和成员。2013年至2015年，卡尔森先生担任Omnicare Inc.（纽约证券交易所代码：OCR）的董事，该公司被CVS制药公司收购。在此之前，他曾于2007年9月至2012年12月担任Amerigroup Corp.的首席执行官、总裁和董事会主席。Amerigroup Corp.是一家由多个州管理的医疗保健公司，在Amerigroup与WellPoint Inc.（现名：Elevance Health, Inc.，纽约证券交易所代码：ELV）合并后退休。2003年至2007年，他担任Amerigroup总裁兼首席运营官。在此之前，他是联合健康公司（纽约证券交易所代码：UNH）的执行副总裁和联合保健业务部门的总裁，该部门为全国超过一千万的HMO和OPPO计划会员提供服务。卡尔森先生的丰富经验还包括在保德信金融集团（纽约证券交易所代码：PRU）工作了17年。卡尔森先生是家庭送餐服务公司PurFoods LLC的董事会成员，也是Guidon Partners的联合创始人。卡尔森先生曾就读于晨兴大学，并毕业于莱德大学。
- James Carlson,began serving as Chair and member of Innovage Holding Corp. Board in June 2022. Mr. Carlson served as director of Omnicare Inc. (NYSE: OCR) from 2013 through 2015 when the company was acquired by CVS Pharmacy, Inc. Prior to that, he was the Chief Executive Officer, President and Chairman of the Board of Amerigroup Corp., a multi-state managed healthcare company, from September 2007 through December 2012, retiring after Amerigroup merged with WellPoint Inc. (now known as Elevance Health, Inc. (NYSE: ELV)). He was Amerigroup's President and Chief Operating Officer from 2003 to 2007. Prior to that, he was Executive Vice President of UnitedHealth Group, Inc. (NYSE: UNH) and President of its UnitedHealthcare business unit, which served more than ten million members in HMO and PPO plans nationwide. Mr. Carlson's diverse experience also includes over 17 years with Prudential Financial, Inc. (NYSE: PRU) Mr. Carlson is a member of the board of directors PurFoods LLC, a home meal delivery service, and is co-founder of Guidon Partners. Mr. Carlson attended Morningside University and graduated from Rider University.
- Teresa Sparks
-
Teresa Sparks，2018年10月至2020年8月担任Envision Healthcare执行副总裁兼首席财务官，Envision Healthcare是一家领先的医生主导服务和急性后服务提供商。在加入Envision之前，Sparks女士是布鲁克代尔高级护理的临时首席财务官，在此之前，她曾担任Surgery Partners的执行副总裁兼首席财务官，该公司于2014年11月收购了Symbion，Inc.，直至2018年1月。斯帕克斯女士还在Symbion担任过多个职位，包括高级副总裁和首席财务官。斯帕克斯的职业生涯始于德勤的审计师。斯帕克斯女士目前担任ATI Physical Therapy（纽约证券交易所代码：ATIP）的董事会成员，同时担任审计委员会成员和合规委员会主席，并担任Harrow Health（纳斯达克：HROW）的审计委员会主席。斯帕克斯女士是注册会计师（非在职），并以优异成绩获得特雷维卡拿撒勒大学会计和工商管理学士学位。
Teresa Sparks,began serving on Innovage Holding Corp. Board in August 2023. Ms. Sparks served as the former Executive Vice President and Chief Financial Officer of Envision Healthcare, a leading provider of physician-led services and post-acute services, from October 2018 to August 2020. Prior to Envision, Ms. Sparks was the interim Chief Financial Officer at Brookdale Senior Living and, prior to that, she served as Executive Vice President and Chief Financial Officer of Surgery Partners, which acquired Symbion, Inc. in November 2014, until January 2018. Ms. Sparks also served in various positions with Symbion, including Senior Vice President and Chief Financial Officer. Ms. Sparks began her career as an auditor at Deloitte. Ms. Sparks currently serves on the board of directors of ATI Physical Therapy, Inc. (NYSE: ATIP), where she also serves as a member of the Audit Committee and Chair of the Healthcare Compliance Committee. Ms. Sparks previously served on the board of directors and chair of the audit committee of Harrow Health, Inc. (Nasdaq: HROW) from 2020 to June 2024. Ms. Sparks is a Certified Public Accountant (inactive) and earned a Bachelor of Science in in Accounting and Business Administration from Trevecca Nazarene University. - Teresa Sparks，2018年10月至2020年8月担任Envision Healthcare执行副总裁兼首席财务官，Envision Healthcare是一家领先的医生主导服务和急性后服务提供商。在加入Envision之前，Sparks女士是布鲁克代尔高级护理的临时首席财务官，在此之前，她曾担任Surgery Partners的执行副总裁兼首席财务官，该公司于2014年11月收购了Symbion，Inc.，直至2018年1月。斯帕克斯女士还在Symbion担任过多个职位，包括高级副总裁和首席财务官。斯帕克斯的职业生涯始于德勤的审计师。斯帕克斯女士目前担任ATI Physical Therapy（纽约证券交易所代码：ATIP）的董事会成员，同时担任审计委员会成员和合规委员会主席，并担任Harrow Health（纳斯达克：HROW）的审计委员会主席。斯帕克斯女士是注册会计师（非在职），并以优异成绩获得特雷维卡拿撒勒大学会计和工商管理学士学位。
- Teresa Sparks,began serving on Innovage Holding Corp. Board in August 2023. Ms. Sparks served as the former Executive Vice President and Chief Financial Officer of Envision Healthcare, a leading provider of physician-led services and post-acute services, from October 2018 to August 2020. Prior to Envision, Ms. Sparks was the interim Chief Financial Officer at Brookdale Senior Living and, prior to that, she served as Executive Vice President and Chief Financial Officer of Surgery Partners, which acquired Symbion, Inc. in November 2014, until January 2018. Ms. Sparks also served in various positions with Symbion, including Senior Vice President and Chief Financial Officer. Ms. Sparks began her career as an auditor at Deloitte. Ms. Sparks currently serves on the board of directors of ATI Physical Therapy, Inc. (NYSE: ATIP), where she also serves as a member of the Audit Committee and Chair of the Healthcare Compliance Committee. Ms. Sparks previously served on the board of directors and chair of the audit committee of Harrow Health, Inc. (Nasdaq: HROW) from 2020 to June 2024. Ms. Sparks is a Certified Public Accountant (inactive) and earned a Bachelor of Science in in Accounting and Business Administration from Trevecca Nazarene University.
- Patricia Fontneau
-
Patricia Fontneau于2021年3月开始在InnovAge Holding Corp.董事会任职。肯尼迪先生是Epstein Becker Green律师事务所的合伙人，这是一家全国性的律师事务所，从事医疗保健和生命科学业务，他从2014年开始在那里执业。2015年至2019年，肯尼迪先生担任康涅狄格州议会的州参议员，2017年至2021年，他担任美国残疾人协会（AAPD）理事会主席，并继续担任AAPD理事会的前任主席。肯尼迪先生目前是生物制药公司Arvinas, Inc.（纳斯达克：ARVN）的董事会成员。肯尼迪在卫斯理大学获得文学学士学位，在耶鲁大学获得环境研究硕士学位，在康涅狄格大学获得法学博士学位。
Patricia Fontneau,began serving on Innovage Holding Corp. Board in March 2023. Ms. Fontneau has served as chief executive officer of Reach Out and Read Colorado, an early literacy nonprofit, since August 2022. Prior to that, Ms. Fontneau served as President of the Benefit and Exchange Technology Solutions health plan business at Cigna from 2014 to 2022. From 2011 to 2014, Ms. Fontneau worked as the chief executive officer at a public health insurance marketplace, Connect for Health Colorado. Ms. Fontneau also ran the operations of Holme Roberts & Owen LLP, an international law firm, from 2008 to 2011. Ms. Fontneau is a member of the boards of ProsperBridge, Public Education & Business Coalition and the Downtown Denver Partnership. Ms. Fontneau earned a Bachelor of Science in Business Administration from the State University of New York at Oswego and a Master of Business Administration in Finance from New York University. - Patricia Fontneau于2021年3月开始在InnovAge Holding Corp.董事会任职。肯尼迪先生是Epstein Becker Green律师事务所的合伙人，这是一家全国性的律师事务所，从事医疗保健和生命科学业务，他从2014年开始在那里执业。2015年至2019年，肯尼迪先生担任康涅狄格州议会的州参议员，2017年至2021年，他担任美国残疾人协会（AAPD）理事会主席，并继续担任AAPD理事会的前任主席。肯尼迪先生目前是生物制药公司Arvinas, Inc.（纳斯达克：ARVN）的董事会成员。肯尼迪在卫斯理大学获得文学学士学位，在耶鲁大学获得环境研究硕士学位，在康涅狄格大学获得法学博士学位。
- Patricia Fontneau,began serving on Innovage Holding Corp. Board in March 2023. Ms. Fontneau has served as chief executive officer of Reach Out and Read Colorado, an early literacy nonprofit, since August 2022. Prior to that, Ms. Fontneau served as President of the Benefit and Exchange Technology Solutions health plan business at Cigna from 2014 to 2022. From 2011 to 2014, Ms. Fontneau worked as the chief executive officer at a public health insurance marketplace, Connect for Health Colorado. Ms. Fontneau also ran the operations of Holme Roberts & Owen LLP, an international law firm, from 2008 to 2011. Ms. Fontneau is a member of the boards of ProsperBridge, Public Education & Business Coalition and the Downtown Denver Partnership. Ms. Fontneau earned a Bachelor of Science in Business Administration from the State University of New York at Oswego and a Master of Business Administration in Finance from New York University.
- John Ellis Bush
-
John Ellis Bush，于2021年3月开始在InnovAge Holding Corp.董事会任职。Bush曾于1999年至2007年担任佛罗里达州州长。Bush先生是IHS Holding有限公司（纽约证券交易所代码：IHS）的董事会成员，该公司是共享电信基础设施的最大独立所有者、运营商和开发商之一。此外，Bush还担任Finback Investment Partners LLC和Dock Square Capital LLC的董事长，这两家商业银行的总部都设在科勒尔盖布尔斯。Bush先生获得了得克萨斯大学奥斯汀分校的文学学士学位。
John Ellis Bush joined the Board of Directors of IHS Holding Limited as a Non Executive Independent Director in Augt 2019. Mr. Bh has served as the President of Jeb Bh & Associates LLC since 2007, and as Chairman and Co founder of Finback Investment Partners LLC since 2019. Mr. Bh has served on the board of directors of InnovAge Holding Corp. since 2021 and Healthedge since 2026. Mr. Bh has also served as Chairman of the Foundation for Excellence in Education since 2007 and on the board of Bloomberg Philanthropies since 2025. Mr. Bh was previoly a senior adviser for Barclays and a board member of Tenet Healthcare Corp. Mr. Bh served as Governor of Florida from 1999 to 2007 and as the Florida Secretary of Commerce from 1986 to 1988. - John Ellis Bush，于2021年3月开始在InnovAge Holding Corp.董事会任职。Bush曾于1999年至2007年担任佛罗里达州州长。Bush先生是IHS Holding有限公司（纽约证券交易所代码：IHS）的董事会成员，该公司是共享电信基础设施的最大独立所有者、运营商和开发商之一。此外，Bush还担任Finback Investment Partners LLC和Dock Square Capital LLC的董事长，这两家商业银行的总部都设在科勒尔盖布尔斯。Bush先生获得了得克萨斯大学奥斯汀分校的文学学士学位。
- John Ellis Bush joined the Board of Directors of IHS Holding Limited as a Non Executive Independent Director in Augt 2019. Mr. Bh has served as the President of Jeb Bh & Associates LLC since 2007, and as Chairman and Co founder of Finback Investment Partners LLC since 2019. Mr. Bh has served on the board of directors of InnovAge Holding Corp. since 2021 and Healthedge since 2026. Mr. Bh has also served as Chairman of the Foundation for Excellence in Education since 2007 and on the board of Bloomberg Philanthropies since 2025. Mr. Bh was previoly a senior adviser for Barclays and a board member of Tenet Healthcare Corp. Mr. Bh served as Governor of Florida from 1999 to 2007 and as the Florida Secretary of Commerce from 1986 to 1988.
- Thomas A. Scully
-
Thomas A. Scully，他于2021年3月开始在Innovage Holding Corp.董事会任职。他于2004年加入WCAS，目前担任医疗保健集团的普通合伙人。他目前担任Select Medical Holdings Corp.（纽约证券交易所代码：SEM）的董事会和薪酬委员会成员，以及Liberty Dental、the Health Management Academy、Tuesday Health和EMERUS Holdings的董事会成员。1989年至1993年，他在白宫和管理和预算办公室担任乔治·h·w·布什总统的健康顾问，2001年至2004年担任乔治·w·布什总统领导下的CMS管理员。他曾担任Universal America Corp.（2008年至2016年出售）和DaVita（纽约证券交易所代码：DVA）的董事会成员（1997年至2001年）等。他持有Virginia大学的文学学士学位和美国Catholic大学的法学博士学位。
Thomas A. Scully has served as a director since February 2004. Since 2004, he has also served as a General Partner with lsh, Carson Anderson & Sto. Since 2017, he has served as a Principal of Lincoln Policy Group. From 2004 to 2017, he served as Senior Counsel to the law firm of Alston & Bird. From May 2001 to January 2004, Mr. Scully served as Administrator of the Centers for Medicare & Medicaid Services, or CMS. CMS is responsible for the management of Medicare, Medicaid, SCHIP and other national healthcare initiatives. Before joining CMS, he served as President and Chief Executive Officer of the Federation of American Hospitals from January 1995 to May 2001. Mr. Scully also serves as a director of InnovAge Holding Corp. and served as a director of Universal American Corp from 2008 until 2017. - Thomas A. Scully，他于2021年3月开始在Innovage Holding Corp.董事会任职。他于2004年加入WCAS，目前担任医疗保健集团的普通合伙人。他目前担任Select Medical Holdings Corp.（纽约证券交易所代码：SEM）的董事会和薪酬委员会成员，以及Liberty Dental、the Health Management Academy、Tuesday Health和EMERUS Holdings的董事会成员。1989年至1993年，他在白宫和管理和预算办公室担任乔治·h·w·布什总统的健康顾问，2001年至2004年担任乔治·w·布什总统领导下的CMS管理员。他曾担任Universal America Corp.（2008年至2016年出售）和DaVita（纽约证券交易所代码：DVA）的董事会成员（1997年至2001年）等。他持有Virginia大学的文学学士学位和美国Catholic大学的法学博士学位。
- Thomas A. Scully has served as a director since February 2004. Since 2004, he has also served as a General Partner with lsh, Carson Anderson & Sto. Since 2017, he has served as a Principal of Lincoln Policy Group. From 2004 to 2017, he served as Senior Counsel to the law firm of Alston & Bird. From May 2001 to January 2004, Mr. Scully served as Administrator of the Centers for Medicare & Medicaid Services, or CMS. CMS is responsible for the management of Medicare, Medicaid, SCHIP and other national healthcare initiatives. Before joining CMS, he served as President and Chief Executive Officer of the Federation of American Hospitals from January 1995 to May 2001. Mr. Scully also serves as a director of InnovAge Holding Corp. and served as a director of Universal American Corp from 2008 until 2017.
- Sean M. Traynor
-
Sean M. Traynor，从2010年开始担任公司董事。 目前他在美国通用金融公司（Universal American Financial Corporation）担任董事。 从1999年开始，他在WCAS公司担任投资专家，目前担任普通合伙人，专注于医疗保健行业的投资。 在加入WCAS公司之前， 从1994年到1996年，他在BT Alex Brown的医疗保健和金融服务投资银行集团任职。 从1991年到1994年，他在永道会计师事务所（Coopers & Lybrand LLP）（现在的普华永道会计师事务所）担任助理和高级经理。他在维拉诺瓦大学（Villanova University）得到学士学位，在沃顿商学院（the Wharton School of Business）得到工商管理硕士学位。
Sean M. Traynor,is currently a general partner of Welsh, Carson, Anderson & Stowe, a private equity investment firm that he joined in March 1999. Mr. Traynor has served as a director for InnovAge Holding Corp., a NASDAQ-listed healthcare company, from 2015 to 2023 and a director of Managed Markets Insights and Technology, LLC, a private consulting company servicing pharmaceutical clients, since 2018. Mr. Traynor previously served as a director for Universal American Financial Corporation, a NYSE-listed health insurer from 2007 to 2016, and K2M, Inc., a provider of medical products from 2010 to 2018. Mr. Traynor previously served as a director for the Company from 2001 until 2013. - Sean M. Traynor，从2010年开始担任公司董事。 目前他在美国通用金融公司（Universal American Financial Corporation）担任董事。 从1999年开始，他在WCAS公司担任投资专家，目前担任普通合伙人，专注于医疗保健行业的投资。 在加入WCAS公司之前， 从1994年到1996年，他在BT Alex Brown的医疗保健和金融服务投资银行集团任职。 从1991年到1994年，他在永道会计师事务所（Coopers & Lybrand LLP）（现在的普华永道会计师事务所）担任助理和高级经理。他在维拉诺瓦大学（Villanova University）得到学士学位，在沃顿商学院（the Wharton School of Business）得到工商管理硕士学位。
- Sean M. Traynor,is currently a general partner of Welsh, Carson, Anderson & Stowe, a private equity investment firm that he joined in March 1999. Mr. Traynor has served as a director for InnovAge Holding Corp., a NASDAQ-listed healthcare company, from 2015 to 2023 and a director of Managed Markets Insights and Technology, LLC, a private consulting company servicing pharmaceutical clients, since 2018. Mr. Traynor previously served as a director for Universal American Financial Corporation, a NYSE-listed health insurer from 2007 to 2016, and K2M, Inc., a provider of medical products from 2010 to 2018. Mr. Traynor previously served as a director for the Company from 2001 until 2013.
- Ted Kennedy, Jr.
-
Ted Kennedy，Jr.于2021年3月开始在InnovAge Holding Corp.董事会任职。肯尼迪先生是全国性律师事务所Epstein Becker Green在医疗保健和生命科学实践领域的合伙人，自2014年以来一直在该领域执业。2015年至2019年，肯尼迪先生在康涅狄格州议会担任州参议员，2017年至2021年，他担任美国残疾人协会（AAPD）董事会主席，并继续担任AAPD董事会的前任主席。肯尼迪先生目前在生物制药公司Arvinas, Inc.（纳斯达克：ARVN）的董事会任职。肯尼迪先生获得了卫斯理大学的文学学士学位、耶鲁大学的环境研究硕士学位以及康涅狄格大学的法学博士学位。
Ted Kennedy, Jr.,began serving on Innovage Holding Corp. Board in March 2021. Mr. Kennedy is a Partner at Epstein Becker Green, a national law firm, in the healthcare and life science practice, where he has practiced since 2014. From 2015 to 2019, Mr. Kennedy served as a State Senator in the Connecticut General Assembly, and from 2017 to 2021, he served as Chair of the Board of the American Association of People with Disabilities (AAPD), and continues to serve on the AAPD Board as Immediate Past Chair. Mr. Kennedy currently serves on the board of directors of Arvinas, Inc. (Nasdaq: ARVN), a biopharmaceutical company. Mr. Kennedy earned a Bachelor of Arts from Wesleyan University, a Master's in Environmental Studies from Yale University, and a Juris Doctor from the University of Connecticut. - Ted Kennedy，Jr.于2021年3月开始在InnovAge Holding Corp.董事会任职。肯尼迪先生是全国性律师事务所Epstein Becker Green在医疗保健和生命科学实践领域的合伙人，自2014年以来一直在该领域执业。2015年至2019年，肯尼迪先生在康涅狄格州议会担任州参议员，2017年至2021年，他担任美国残疾人协会（AAPD）董事会主席，并继续担任AAPD董事会的前任主席。肯尼迪先生目前在生物制药公司Arvinas, Inc.（纳斯达克：ARVN）的董事会任职。肯尼迪先生获得了卫斯理大学的文学学士学位、耶鲁大学的环境研究硕士学位以及康涅狄格大学的法学博士学位。
- Ted Kennedy, Jr.,began serving on Innovage Holding Corp. Board in March 2021. Mr. Kennedy is a Partner at Epstein Becker Green, a national law firm, in the healthcare and life science practice, where he has practiced since 2014. From 2015 to 2019, Mr. Kennedy served as a State Senator in the Connecticut General Assembly, and from 2017 to 2021, he served as Chair of the Board of the American Association of People with Disabilities (AAPD), and continues to serve on the AAPD Board as Immediate Past Chair. Mr. Kennedy currently serves on the board of directors of Arvinas, Inc. (Nasdaq: ARVN), a biopharmaceutical company. Mr. Kennedy earned a Bachelor of Arts from Wesleyan University, a Master's in Environmental Studies from Yale University, and a Juris Doctor from the University of Connecticut.
高管简历
中英对照 | 中文 | 英文- Nicole D'Amato
Nicole D’Amato自2021年7月起担任我们的首席法务官兼公司秘书。在加入Innovage之前，自2015年以来，D’Amato女士是MacAndrews&Forbes的高级副总裁，这是一家拥有Revlon Inc.多数股份的运营公司。纽约证券交易所代码:REV，是Scientific Games（纳斯达克代码:SGMS）的最大股东，并拥有Merisant Company等其他私人公司。在此之前，2011年至2015年，D’Amato女士曾担任Diageo North America，Inc.（全球领先的酒精饮料业务）的董事兼高级法律顾问，并担任Samsonite，LLC的知识产权全球主管兼助理公司秘书，从2010年到2011年，她参与了公司在香港证券交易所的首次公开发行。她的法律职业生涯始于任职Ropes&Gray LLP，在那里她曾担任知识产权和公司事务律师。D’Amato女士在纽约州伊萨卡的康奈尔大学以优异成绩获得了文学学士学位，并在田纳西州纳什维尔的范德比尔特大学法学院获得了法学博士学位。
Nicole D'Amato,has served as Innovage Holding Corp. Chief Legal Officer and Corporate Secretary since July 2021. Prior to joining InnovAge and since 2015, Ms. D'Amato was Senior Vice President at MacAndrews & Forbes, an operating company which owned the majority shares of Revlon Inc. (NYSE: REV), was the largest stockholder of Scientific Games (Nasdaq: SGMS) and owned other private companies such as Merisant Company. Prior to that, Ms. D'Amato worked as a Director and Senior Counsel at DIAGEO North America, Inc., the world's leading alcohol beverage business, from 2011 to 2015, and as Global Head of Intellectual Property and Assistant Corporate Secretary at Samsonite, LLC, from 2010 to 2011, where she participated in the company's initial public offering on the Hong Kong Stock Exchange. Ms. D'Amato started her legal career at Ropes & Gray LLP where she practiced as an intellectual property and corporate transactional attorney. Ms. D'Amato earned her Bachelor of Arts at Cornell University, in Ithaca, New York, and a Doctor of Jurisprudence from Vanderbilt University Law School in Nashville, Tennessee.- Nicole D’Amato自2021年7月起担任我们的首席法务官兼公司秘书。在加入Innovage之前，自2015年以来，D’Amato女士是MacAndrews&Forbes的高级副总裁，这是一家拥有Revlon Inc.多数股份的运营公司。纽约证券交易所代码:REV，是Scientific Games（纳斯达克代码:SGMS）的最大股东，并拥有Merisant Company等其他私人公司。在此之前，2011年至2015年，D’Amato女士曾担任Diageo North America，Inc.（全球领先的酒精饮料业务）的董事兼高级法律顾问，并担任Samsonite，LLC的知识产权全球主管兼助理公司秘书，从2010年到2011年，她参与了公司在香港证券交易所的首次公开发行。她的法律职业生涯始于任职Ropes&Gray LLP，在那里她曾担任知识产权和公司事务律师。D’Amato女士在纽约州伊萨卡的康奈尔大学以优异成绩获得了文学学士学位，并在田纳西州纳什维尔的范德比尔特大学法学院获得了法学博士学位。
- Nicole D'Amato,has served as Innovage Holding Corp. Chief Legal Officer and Corporate Secretary since July 2021. Prior to joining InnovAge and since 2015, Ms. D'Amato was Senior Vice President at MacAndrews & Forbes, an operating company which owned the majority shares of Revlon Inc. (NYSE: REV), was the largest stockholder of Scientific Games (Nasdaq: SGMS) and owned other private companies such as Merisant Company. Prior to that, Ms. D'Amato worked as a Director and Senior Counsel at DIAGEO North America, Inc., the world's leading alcohol beverage business, from 2011 to 2015, and as Global Head of Intellectual Property and Assistant Corporate Secretary at Samsonite, LLC, from 2010 to 2011, where she participated in the company's initial public offering on the Hong Kong Stock Exchange. Ms. D'Amato started her legal career at Ropes & Gray LLP where she practiced as an intellectual property and corporate transactional attorney. Ms. D'Amato earned her Bachelor of Arts at Cornell University, in Ithaca, New York, and a Doctor of Jurisprudence from Vanderbilt University Law School in Nashville, Tennessee.
- Patrick Blair
Patrick Blair自2021年12月1日起担任我们的总裁，自2022年1月1日起担任我们的首席执行官。在加入Innovage之前，Blair先生自2020年8月起在Bayada Home Health Care Inc.担任集团总裁，负责家庭健康，临终关怀和个人护理业务的整体质量和财务表现。在加入Bayada Home Health Care Inc.之前，Blair先生是Anthem, Inc.商业业务部门的高级副总裁。纽约证券交易所:ANTM，是美国最大和最多元化的医疗福利提供者之一。在那里，他领导个人、小型集团和大型集团业务部门，负责推动盈利增长。在Anthem, Inc.任职期间，他还担任首席营销官。Blair先生于2012年12月至2020年7月在Anthem, Inc.任职。在此之前，Blair先生从2004年到2012年12月在Amerigroup Corporation工作，并担任过许多领导职务，包括首席营销和业务开发官以及特种产品首席执行官。Blair先生的职业生涯始于Ernst&Young LLP和Deloitte Consulting，服务于全国领先的供应商和付款人医疗保健组织。布莱尔先生在印第安纳大学布卢明顿分校获得经济学学士学位，在印第安纳大学普渡大学印第安纳波利斯分校获得卫生保健管理硕士学位，并在亨利商学院获得工商管理硕士学位。
Patrick Blair,has served as Innovage Holding Corp. President since December, 2021 and as Innovage Holding Corp. Chief Executive Officer since January, 2022. Prior to joining InnovAge, Mr. Blair worked at BAYADA Home Health Care Inc. as the Group President responsible for the overall quality and financial performance of the Home Health, Hospice and Personal Care businesses since August 2020. Prior to BAYADA Home Health Care Inc., Mr. Blair was the Senior Vice President for Commercial Business Segments at Anthem, Inc. (NYSE: ANTM), one of the nation's largest and most diversified health benefit providers. There, he led the Individual, Small Group and Large Group business segments where he was responsible for driving profitable growth. During his tenure at Anthem, Inc., he also served as Chief Marketing Officer. Mr. Blair was with Anthem, Inc. from December 2012 to July 2020. Prior to that, Mr. Blair was with Amerigroup Corporation from 2004 to December 2012 and served in a number of leadership roles, including Chief Marketing and Business Development Officer and Chief Executive Officer of Specialty Products. Mr. Blair began his career at Ernst & Young LLP and Deloitte Consulting, serving the nation's leading provider and payer healthcare organizations. Mr. Blair earned a Bachelor's degree in Economics from Indiana University Bloomington, a Master's of Health Care Administration and Management from Indiana University-Purdue University Indianapolis and a Master's of Business Administration from Henley Business School.- Patrick Blair自2021年12月1日起担任我们的总裁，自2022年1月1日起担任我们的首席执行官。在加入Innovage之前，Blair先生自2020年8月起在Bayada Home Health Care Inc.担任集团总裁，负责家庭健康，临终关怀和个人护理业务的整体质量和财务表现。在加入Bayada Home Health Care Inc.之前，Blair先生是Anthem, Inc.商业业务部门的高级副总裁。纽约证券交易所:ANTM，是美国最大和最多元化的医疗福利提供者之一。在那里，他领导个人、小型集团和大型集团业务部门，负责推动盈利增长。在Anthem, Inc.任职期间，他还担任首席营销官。Blair先生于2012年12月至2020年7月在Anthem, Inc.任职。在此之前，Blair先生从2004年到2012年12月在Amerigroup Corporation工作，并担任过许多领导职务，包括首席营销和业务开发官以及特种产品首席执行官。Blair先生的职业生涯始于Ernst&Young LLP和Deloitte Consulting，服务于全国领先的供应商和付款人医疗保健组织。布莱尔先生在印第安纳大学布卢明顿分校获得经济学学士学位，在印第安纳大学普渡大学印第安纳波利斯分校获得卫生保健管理硕士学位，并在亨利商学院获得工商管理硕士学位。
- Patrick Blair,has served as Innovage Holding Corp. President since December, 2021 and as Innovage Holding Corp. Chief Executive Officer since January, 2022. Prior to joining InnovAge, Mr. Blair worked at BAYADA Home Health Care Inc. as the Group President responsible for the overall quality and financial performance of the Home Health, Hospice and Personal Care businesses since August 2020. Prior to BAYADA Home Health Care Inc., Mr. Blair was the Senior Vice President for Commercial Business Segments at Anthem, Inc. (NYSE: ANTM), one of the nation's largest and most diversified health benefit providers. There, he led the Individual, Small Group and Large Group business segments where he was responsible for driving profitable growth. During his tenure at Anthem, Inc., he also served as Chief Marketing Officer. Mr. Blair was with Anthem, Inc. from December 2012 to July 2020. Prior to that, Mr. Blair was with Amerigroup Corporation from 2004 to December 2012 and served in a number of leadership roles, including Chief Marketing and Business Development Officer and Chief Executive Officer of Specialty Products. Mr. Blair began his career at Ernst & Young LLP and Deloitte Consulting, serving the nation's leading provider and payer healthcare organizations. Mr. Blair earned a Bachelor's degree in Economics from Indiana University Bloomington, a Master's of Health Care Administration and Management from Indiana University-Purdue University Indianapolis and a Master's of Business Administration from Henley Business School.
- Richard Feifer
Richard Feifer，自2022年8月起担任InnovAge Holding Corp.首席医疗官。他还于2022年4月创立了英国皇家空军医疗保健解决方案有限责任公司，目前为医疗保健行业提供临时咨询服务。在此之前，Feifer博士曾在Genesis HealthCare担任多个职位，Genesis HealthCare是一家控股公司，其子公司为熟练护理和辅助/老年生活设施提供服务，包括2020年5月至2022年4月担任执行副总裁，2019年1月至2022年4月担任Genesis Physician Services & Genesis HealthCare CMO总裁，2016年4月至2019年1月担任Genesis Physician Services和Genesis LTC ACO CMO。在此之前，他曾于2010年11月至2016年4月担任安泰保险国民账户首席营销官。费弗博士目前还担任非盈利医疗保健认证组织卫生保健认证委员会的董事会成员。费弗博士在布朗大学获得学士学位，在哥伦比亚大学获得公共卫生硕士学位，在宾夕法尼亚大学获得医学博士学位。
Richard Feifer,has served as Innovage Holding Corp. Chief Medical Officer since August 2022. Prior to joining the Company, Dr. Feifer held various positions at Genesis HealthCare, a holding company with subsidiaries that provide services to skilled nursing and assisted/senior living facilities, including as executive vice president from May 2020 to April 2022, president of Genesis Physician Services and chief medical officer of Genesis HealthCare from January 2019 to April 2022, and chief medical officer of Genesis Physician Services and Genesis LTC ACO from April 2016 to January 2019. Prior to that, he served as chief medical officer of National Accounts, Aetna, from November 2010 to April 2016. Dr. Feifer also currently serves on the board of directors of Accreditation Commission for Health Care, a non-profit healthcare accrediting organization. He also provides occasional advisory services to the healthcare industry as a board or committee member, through RAF Healthcare Solutions LLC. Dr. Feifer earned a Bachelor of Arts in Human Biology from Brown University, a Master's in Public Health from Columbia University and a Doctor of Medicine from University of Pennsylvania.- Richard Feifer，自2022年8月起担任InnovAge Holding Corp.首席医疗官。他还于2022年4月创立了英国皇家空军医疗保健解决方案有限责任公司，目前为医疗保健行业提供临时咨询服务。在此之前，Feifer博士曾在Genesis HealthCare担任多个职位，Genesis HealthCare是一家控股公司，其子公司为熟练护理和辅助/老年生活设施提供服务，包括2020年5月至2022年4月担任执行副总裁，2019年1月至2022年4月担任Genesis Physician Services & Genesis HealthCare CMO总裁，2016年4月至2019年1月担任Genesis Physician Services和Genesis LTC ACO CMO。在此之前，他曾于2010年11月至2016年4月担任安泰保险国民账户首席营销官。费弗博士目前还担任非盈利医疗保健认证组织卫生保健认证委员会的董事会成员。费弗博士在布朗大学获得学士学位，在哥伦比亚大学获得公共卫生硕士学位，在宾夕法尼亚大学获得医学博士学位。
- Richard Feifer,has served as Innovage Holding Corp. Chief Medical Officer since August 2022. Prior to joining the Company, Dr. Feifer held various positions at Genesis HealthCare, a holding company with subsidiaries that provide services to skilled nursing and assisted/senior living facilities, including as executive vice president from May 2020 to April 2022, president of Genesis Physician Services and chief medical officer of Genesis HealthCare from January 2019 to April 2022, and chief medical officer of Genesis Physician Services and Genesis LTC ACO from April 2016 to January 2019. Prior to that, he served as chief medical officer of National Accounts, Aetna, from November 2010 to April 2016. Dr. Feifer also currently serves on the board of directors of Accreditation Commission for Health Care, a non-profit healthcare accrediting organization. He also provides occasional advisory services to the healthcare industry as a board or committee member, through RAF Healthcare Solutions LLC. Dr. Feifer earned a Bachelor of Arts in Human Biology from Brown University, a Master's in Public Health from Columbia University and a Doctor of Medicine from University of Pennsylvania.
- Benjamin C. Adams
Benjamin C. Adams，自2023年7月起担任InnovAge Holding Corp.首席财务官。从2021年到2023年6月，亚当斯先生担任Kepro（Keystone Peer Review Organization，Inc.）的首席财务官，该公司是一家医疗保健公司，为全国各地的政府资助和商业健康支付者提供技术服务，他于2021年加入该公司。亚当斯先生于2018年至2021年在RxSense，LLC担任执行副总裁兼首席财务官，该公司是一家领先的医疗保健技术公司，提供直接面向消费者的药房折扣计划和B2B技术解决方案。在此之前，亚当斯先生是一位资深的医疗保健投资银行家，工作了二十多年。亚当斯先生在塔夫茨大学获得经济学学士学位，在哥伦比亚大学商学院获得工商管理硕士学位。
Benjamin C. Adams,has served as Innovage Holding Corp. Chief Financial Officer since July 2023. From 2021 to June 2023, Mr. Adams was the chief financial officer of Kepro (Keystone Peer Review Organization, Inc.), a healthcare company providing technology services to government-sponsored and commercial health payers across the country, which he joined in 2021. Mr. Adams worked as executive vice president and chief financial officer at RxSense, LLC, a leading healthcare technology company providing direct to consumer pharmacy discount programs and B2B technology solutions, from 2018 to 2021. Previously, Mr. Adams was a senior healthcare investment banker for more than two decades. Mr. Adams earned a Bachelor of Arts in Economics from Tufts University and a Master's of Business Administration from Columbia Business School.- Benjamin C. Adams，自2023年7月起担任InnovAge Holding Corp.首席财务官。从2021年到2023年6月，亚当斯先生担任Kepro（Keystone Peer Review Organization，Inc.）的首席财务官，该公司是一家医疗保健公司，为全国各地的政府资助和商业健康支付者提供技术服务，他于2021年加入该公司。亚当斯先生于2018年至2021年在RxSense，LLC担任执行副总裁兼首席财务官，该公司是一家领先的医疗保健技术公司，提供直接面向消费者的药房折扣计划和B2B技术解决方案。在此之前，亚当斯先生是一位资深的医疗保健投资银行家，工作了二十多年。亚当斯先生在塔夫茨大学获得经济学学士学位，在哥伦比亚大学商学院获得工商管理硕士学位。
- Benjamin C. Adams,has served as Innovage Holding Corp. Chief Financial Officer since July 2023. From 2021 to June 2023, Mr. Adams was the chief financial officer of Kepro (Keystone Peer Review Organization, Inc.), a healthcare company providing technology services to government-sponsored and commercial health payers across the country, which he joined in 2021. Mr. Adams worked as executive vice president and chief financial officer at RxSense, LLC, a leading healthcare technology company providing direct to consumer pharmacy discount programs and B2B technology solutions, from 2018 to 2021. Previously, Mr. Adams was a senior healthcare investment banker for more than two decades. Mr. Adams earned a Bachelor of Arts in Economics from Tufts University and a Master's of Business Administration from Columbia Business School.